Related Experiment Videos
Using a 6-minute walk test to predict outcomes in patients with left ventricular dysfunction
N P Milligan1, J Havey, A Dossa
1Cardiology Department, Spaulding Rehabilitation Hospital, Boston, MA 02114, USA.
Summary
The 6-minute walk test effectively predicts mortality in patients with left ventricular dysfunction (LVD). A longer walk distance at discharge indicates a higher survival rate, offering a simpler alternative to VO2MAX testing.
Area of Science:
- Cardiology
- Rehabilitation Medicine
- Clinical Outcomes
Background:
- Maximal oxygen consumption (VO2MAX) is a key predictor of outcomes in patients with left ventricular dysfunction (LVD).
- Measuring VO2MAX is often impractical in rehabilitation settings due to cost, time, and patient limitations.
Purpose of the Study:
- To evaluate the 6-minute walk test (6MWT) as a simpler, cost-effective predictor of mortality in LVD patients.
- To determine if 6MWT performance can guide prognosis and treatment planning for cardiac rehabilitation patients.
Main Methods:
- Sixty-six patients with LVD undergoing Phase 1 cardiac rehabilitation participated.
- The 6-minute walk test was administered at admission and discharge.
- Survival rates were tracked 3 months post-discharge.
Main Results:
- Patients who walked longer distances at discharge demonstrated a significantly higher survival rate at 3 months.
- The 6MWT proved to be a valuable prognostic tool in this cohort.
Conclusions:
- The 6-minute walk test is a feasible and effective tool for predicting mortality in LVD patients within a rehabilitation setting.
- Findings support the use of 6MWT for informing treatment plans, prognosis, and discharge decisions for deconditioned LVD patients.